OncoSynergy Information

Our vision: "Cancer treatment in one dose." OncoSynergy is a patient-focused biotechnology startup spun out from UCSF and the JLABS South San Francisco incubator. Based in bustling Stamford, Connecticut (~40 mins from NYC), we are creating a new class of cancer medicines to maximize patient survival and quality of life with minimal side effects. We are a small, nimble startup team that launched our first clinical trial in 2020 for glioblastoma (aggressive brain cancer). While we are at the forefront of potential game changing research, please support our patients. They need you to spread awareness far and wide so that more research is being dedicated to devastating cancers like glioblastoma.

Website	http://www.oncosynergy.com/
Revenue	$811000
Employees	4 (4 on RocketReach)
Founded	2011
Phone	+1 415-299-4249
Technologies	JavaScript , HTML , PHP +27 more (view full list)
Industry	Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Medical Device, Therapeutics
Web Rank	27 Million
Keywords	Cancer Treatment, Biotechnology, Oncology, Drug Development, Pharmaceutical, Cancer Research, Clinical Trials, Immunotherapy, Targeted Therapy, Precision Medicine, Biopharma, Novel Therapies, Cancer Drugs, Healthcare, Life Sciences, Patient Focused, Medical Research, Drug Discovery
Competitors	Roche, Novartis, Merck & Co., Inc., Bristol Myers Squibb, Genentech, Amgen, Gilead Sciences, Eisai Co., Ltd., Exelixis, Receptos, a wholly-owned subsidiary of Celgene +45 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies